Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP.

BMC Cancer. 2008 Jun 11;8:170. doi: 10.1186/1471-2407-8-170.

2.

Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.

Michelassi F, Erroi F, Dawson PJ, Pietrabissa A, Noda S, Handcock M, Block GE.

Ann Surg. 1989 Oct;210(4):544-54; discussion 554-6. Review.

3.

Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma.

Kennedy EP, Yeo CJ.

Surg Oncol Clin N Am. 2007 Jan;16(1):157-76. Review.

PMID:
17336242
4.

Resection margin involvement and tumour origin in pancreatic head cancer.

Verbeke CS, Gladhaug IP.

Br J Surg. 2012 Aug;99(8):1036-49. doi: 10.1002/bjs.8734. Epub 2012 Apr 20. Review.

PMID:
22517199
5.

Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival.

Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, Verbeek PC, de Wit LT, Gouma DJ.

Surgery. 1995 Mar;117(3):247-53. Review.

PMID:
7878528
6.

Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.

Ramfidis VS, Syrigos KN, Saif MW.

JOP. 2013 Mar 10;14(2):158-60. doi: 10.6092/1590-8577/1471. Review.

7.

Ampullary cancer--a separate clinical entity?

Perysinakis I, Margaris I, Kouraklis G.

Histopathology. 2014 May;64(6):759-68. doi: 10.1111/his.12324. Epub 2014 Jan 24. Review.

PMID:
24456259
8.

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.

Smith RA, Tang J, Tudur-Smith C, Neoptolemos JP, Ghaneh P.

Br J Cancer. 2011 Apr 26;104(9):1440-51. doi: 10.1038/bjc.2011.110. Epub 2011 Mar 29. Review.

9.

Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Panzeri F, Crippa S, Castelli P, Aleotti F, Pucci A, Partelli S, Zamboni G, Falconi M.

World J Gastroenterol. 2015 Jul 14;21(26):7970-87. doi: 10.3748/wjg.v21.i26.7970. Review.

10.

Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.

Erdmann JI, Eskens FA, Vollmer CM, Kok NF, Groot Koerkamp B, Biermann K, van Eijck CH.

Ann Surg Oncol. 2015 Jul;22(7):2401-7. doi: 10.1245/s10434-014-4267-4. Epub 2014 Dec 12. Review.

PMID:
25503345
11.

Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

La Torre M, Nigri G, Ferrari L, Cosenza G, Ravaioli M, Ramacciato G.

Am Surg. 2012 Feb;78(2):225-9. Review.

PMID:
22369834
12.

Prognostic factors in resectable pancreatic cancer.

Surlin V, Bintintan V, Petrariu FD, Dobrin R, Lefter R, Ciobică A, Timofte D.

Rev Med Chir Soc Med Nat Iasi. 2014 Oct-Dec;118(4):924-31. Review.

PMID:
25581949
13.

Well differentiation and intact Smad4 expression are specific features of groove pancreatic ductal adenocarcinomas.

Izumi S, Nakamura S, Mano S, Akaki S.

Pancreas. 2015 Apr;44(3):394-400. doi: 10.1097/MPA.0000000000000260. Review.

PMID:
25426619
14.

Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.

Walter U, Kohlert T, Rahbari NN, Weitz J, Welsch T.

Ann Surg Oncol. 2014 Apr;21(4):1082-9. doi: 10.1245/s10434-013-3415-6. Epub 2013 Dec 10. Review.

PMID:
24322532
15.

Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.

Johnston WC, Hoen HM, Cassera MA, Newell PH, Hammill CW, Hansen PD, Wolf RF.

HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21. Review.

16.

Postoperative radiotherapy in periampullary cancers: a brief review.

Bahl A, Bhattacharyya T, Kapoor R, Singh OA, Parsee T, Sharma SC.

J Gastrointest Cancer. 2013 Mar;44(1):111-4. doi: 10.1007/s12029-012-9421-2. Review.

PMID:
22843209
17.

[Adenocarcinomas of the pancreas: how best to evaluate resectability?].

Barthet M, Moutardier V, Marciano S.

Gastroenterol Clin Biol. 2007 Feb;31(2):216-21. Review. French. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk